Results 101 to 110 of about 42,587 (212)

AI and Big Data in Oncology: A Physician‐Centered Perspective on Emerging Clinical and Research Applications

Cancer Innovation, Volume 5, Issue 1, February 2026.
Artificial intelligence and big data platforms are transforming oncology clinical practice. This review proposes a physician‐centered framework to integrate AI tools with real‐world data, supporting more precise diagnosis, individualized treatment, and improved patient outcomes.
Binliang Liu, Qingyao Shang, Jun Li, Shuna Yao, Meishuo Ouyang, Yu Wang, Sheng Luo, Quchang Ouyang   +7 more
wiley   +1 more source

Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma with Cardiac Metastasis and Arterial Tumor Embolisms during First-Course Chemotherapy

Case Reports in Oncology, 2016
We described an 11-year-old boy suffering from pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with heart metastasis at diagnosis and arterial tumor embolisms during chemotherapy.
Kozo Nagai, Yukari Suyama, Daisuke Koga, Masanori Nishi, Chiaki Iida, Katsuya Tashiro, Atsushi Danjo, Keita Kai, Muneaki Matsuo   +8 more
doaj   +1 more source

ALK-negative anaplastic large cell lymphoma primarily involving the bronchus: A case report and literature review [PDF]

, 2013
Anaplastic large cell lymphoma (ALCL) is a mature T cell lymphoma with characteristic morphologic, immunophenotypic and cytogenetic features. Current WHO classification includes anaplastic lymphoma kinase (ALK)-positive and ALK-negative variants.
Xu, Xiangdong
core   +2 more sources

GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers [PDF]

, 2012
Background: Increased glycolytic activity is a hallmark of cancer, allowing staging and restaging with 18F-fluorodeoxyglucose-positron-emission-tomography (PET).
Agostinelli, Claudio, Bergmann, Lothar, Diener, Jürgen, Döring, Claudia, Fanti, Stefano, Gallamini, Andrea, Hansmann, Martin-Leo, Hartmann, Sylvia, Pileri, Stefano, Zinzani, Pier Luigi   +9 more
core   +1 more source

A Clinical Guidance for the Management of Patients With Hepatoid Adenocarcinoma and A Case Series

Cancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Hepatoid adenocarcinoma (HAC) is a rare extrahepatic tumor of non‐germ cell origin that morphologically resembles hepatocellular carcinoma (HCC). HAC has a propensity to metastasize to the liver and therefore may be mistaken for HCC. There is a lack of standardized treatment protocols, and further studies are needed to evaluate the benefit of ...
Christina Liava, Sudhakar Venkatesh, Michael S. Torbenson, Patrick S. Kamath, Moira Hilscher   +4 more
wiley   +1 more source

T-cell lymphoma in South America and Europe. [PDF]

, 2012
Peripheral T-cell lymphomas are a group of rare neoplasms originating from clonal proliferation of mature post-thymic lymphocytes with different entities having specific biological characteristics and clinical features.
BELLEI, Monica, Cabrera M. E., Chiattone C. S., Connors J. M., de Souza A. C., FEDERICO, Massimo, Foss F. M., Gabùs R., Horwitz S. M., Liang R., LUMINARI, Stefano, Milone J., Montolo S., Pavlovsky A., PESCE, Emanuela Anna, Pileri S. A., Polliak A., Vose J. M., Zinzani P. L., Zoppegno L., Zucca E.   +20 more
core   +1 more source

A Giant Thoracic ALK‐Rearranged Mesenchymal Neoplasm in a Child

Cancer Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background Mesenchymal neoplasms characterized by ALK fusions mainly include inflammatory myofibroblastic tumors (IMTs) and epithelioid fibrous histiocytomas (EFHs). More recently, ALK‐rearranged mesenchymal tumors that are not IMTs or EFHs, characterized by S100 and CD34 coexpression, have been reported in a few small series and isolated case
Sheng Gao, Junhua Wu, Jun Fan, Xiaona Chang, Bo Huang, Danju Luo, Jun He, Heshui Shi, Xiaochuan Dong, Xiu Nie   +9 more
wiley   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic‐cell clearance to therapeutic targeting

Clinical and Translational Medicine, Volume 16, Issue 2, February 2026.
This review systematically deconstructs the pathological efferocytic—metabolic axis in tumours, framing it as a three‐stage, self‐reinforcing cycle: from metabolite‐driven macrophage recruitment, through hijacked surface recognition, to post‐phagocytic metabolic reprogramming that locks in immunosuppression.
Qianlu Yang, Jie Yan, Qianxi Yang
wiley   +1 more source

Anaplastic lymphoma kinase positive variant of anaplastic large cell lymphoma: A rare entity

Journal of Indian Academy of Oral Medicine and Radiology, 2014
Anaplastic large cell lymphoma (ALCL) is a distinct clinicopathological entity of non-Hodgkin′s lymphoma, which has been included as a T-cell neoplasm in the World Health Organization classification, with peculiar features such as painless ...
Venkata Satya Ramesh Thummala, Sreenidhi Banda, Vinay Kumar Reddy Kundoor, Kotya Naik Maloth   +3 more
doaj   +1 more source

ALK Expression in Nerve Sheath Myxoma: A Potential Diagnostic Pitfall

Journal of Cutaneous Pathology, EarlyView.
Daniel Cole, May P. Chan, Douglas Rottmann, Bryan L. Betz, Noah Brown, Venezia Podesta, Paul W. Harms   +6 more
wiley   +1 more source